Literature DB >> 1329268

Phosphoinositide hydrolysis and calcium mobilization induced by vasopressin and angiotensin II in cultured vascular smooth muscle cells.

K Takeuchi1, K Abe, M Yasujima, M Sato, K Maeyama, T Watanabe, S Sato, H Inaba, K Yoshinaga.   

Abstract

The cellular action of vasoconstrictive hormones, angiotensin II (AII) and Arg8-vasopressin (AVP), on vascular smooth muscle (VSM) in cultured VSM cells from rat mesenteric artery was studied. Both AII and AVP specifically induce a transient increases in cytosolic free calcium independent of extracellular calcium or calcium channels activated by high potassium depolarization in VSM cells loaded with Fura-2. Vasoconstrictive hormones induce a dose-dependency with formation of inositolphosphates. Analysis using high pressure liquid chromatography has shown that AVP stimulates rapid and transient increases in inositol 1,3,4-trisphosphate, inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate within 1 minute. Moreover, a laser-excitation fluorescence system reveals high calcium concentration sites in subsarcolemmal region. These results indicate that, unlike voltage-dependent calcium influx across the cell membrane, AII and AVP induce receptor-mediated increases in cytosolic free calcium via phosphoinositide hydrolysis creating an intracellular messenger for calcium release from intracellular calcium stores.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329268     DOI: 10.1620/tjem.166.107

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin.

Authors:  Rachel W Fallet; Hideki Ikenaga; Joseph P Bast; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-09

2.  Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization.

Authors:  T Abe; K Takeuchi; N Takahashi; E Tsutsumi; Y Taniyama; K Abe
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.